document.write(''); document.write('
'); document.write(' '); document.write('

ReTweet if useful... Dalbavancin use in vulnerable patients receiving OPAT https://ctt.ec/55OTb+ @ivteam #ivteam

'); document.write('
Click To Tweet
'); document.write('
'); document.write('
');